Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease

Metabolism: Clinical and Experimental

Volumn 56, Issue 7, 2007, Pages 881-886

  Lautamäki, Riikka ^a   Rönnemaa, Tapani ^a   Huupponen, Risto ^a,b   Lehtimäki, Terho ^c   Iozzo, Patricia ^a,d   Airaksinen, K E Juhani ^a   Knuuti, Juhani ^a   Nuutila, Pirjo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY WALL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE TRANSPORT; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; AGED; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 34250172420     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.01.018     Document Type: Article

References (27)

1. Tsimikas S., Brilakis E.S., Miller E.R., McConnell J.P., Lennon R.J., Kornman K.S., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353 (2005) 46-57
2. Liu K.H., Chan Y.L., Chan J.C., Chan W.B., Kong M.O., and Poon M.Y. The preferred magnetic resonance imaging planes in quantifying visceral adipose tissue and evaluating cardiovascular risk. Diabetes Obes Metab 7 (2005) 547-554
3. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
4. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
5. von Eynatten M., Schneider J.G., Humpert P.M., Kreuzer J., Kuecherer H., Katus H.A., et al. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. J Am Coll Cardiol 47 (2006) 2124-2126
6. Rothenbacher D., Brenner H., Marz W., and Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur J Heart 26 (2005) 1640-1646
7. Odamaki M., Furuya R., Kinumura Y., Ikegaya N., and Kumagai H. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients. Nephron Clin Pract 102 (2005) c8-c13
8. Lautamaki R., Airaksinen K.E., Seppanen M., Toikka J., Luotolahti M., Ball E., et al. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study. Diabetes 54 (2005) 2787-2794
9. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
10. Jarvisalo M.J., Harmoinen A., Hakanen M., Paakkunainen U., Viikari J., Hartiala J., et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 22 (2002) 1323-1328
11. Metso S., Loimaala A., Mercuri M.F., Nenonen A., Vuori I., Oja P., et al. Circulating oxidized low-density lipoprotein and common carotid artery intima-media thickness in a random sample of middle-aged men. J Biomed Sci 11 (2004) 356-361
12. Laaksonen R., Janatuinen T., Vesalainen R., Lehtimaki T., Elovaara I., Jaakkola O., et al. High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults. Eur J Clin Invest 32 (2002) 795-802
13. Myers G.L., Rifai N., Tracy R.P., Roberts W.L., Alexander R.W., Biasucci L.M., et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to clinical and public health practice: report from the laboratory science discussion group. Circulation 110 (2004) e545-e549
14. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
15. Kwon K., Jung S.H., Choi C., and Park S.H. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women. Int J Cardiol 101 (2005) 385-390
16. Mertens A., and Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 15 (2001) 2073-2084
17. Toshima S., Hasegawa A., Kurabayashi M., Itabe H., Takano T., Sugano J., et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20 (2000) 2243-2247
18. Vindis C., Escargueil-Blanc I., Elbaz M., Marcheix B., Grazide M.H., Uchida K., et al. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers. Circ Res 98 (2006) 785-792
19. Motoshima H., Wu X., Mahadev K., and Goldstein B.J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 315 (2004) 264-271
20. Otsuka F., Sugiyama S., Kojima S., Maruyoshi H., Funahashi T., Matsui K., et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 48 (2006) 1155-1162
21. Goldstein B.J., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
22. Loskutoff D.J., and Samad F. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 18 (1998) 1-6
23. Alessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., and Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46 (1997) 860-867
24. Ishikawa T., Imamura T., Hatakeyama K., Date H., Nagoshi T., Kawamoto R., et al. Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation. Am J Cardiol 93 (2004) 611-614
25. Calabro P., Chang D.W., Willerson J.T., and Yeh E.T. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 46 (2005) 1112-1113
26. Calabro P., Willerson J.T., and Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 (2003) 1930-1932
27. Nakamura T., Kodama Y., Takano H., Umetani K., Fujioka D., Saito Y., et al. Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia. Atherosclerosis (2006)